According to the recent study the stem cell therapy market is projected to reach an estimated $0.9 billion by 2028 from $0.4 billion in 2023, at a CAGR of 14.7% from 2023 to 2028. Growth in this market is primarily driven by growing number of cell therapy production facilities, increasing number of clinical trials associated with stem cell therapies, and robust government funding for stem cell research.

A more than 150 – page report is developed to understand trends, opportunities and forecast in stem cell therapy market by type (allogeneic stem cell therapy and autologous stem cell therapy), cell source (adipose tissue-derived MSCs (mesenchymal stem cells), bone marrow-derived MSCs, placental/umbilical cord-derived MSCs, and others), application (musculoskeletal disorders, wounds & injuries, cardiovascular diseases, surgeries, inflammatory & autoimmune diseases, neurological disorders, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Download sample report by clicking on below link https://www.lucintel.com/stem-cell-therapy-market.aspx

“Allogeneic stem cell therapy market is expected to remain the largest segment during the forecast period.”

Based on type, the stem cell therapy market is segmented into allogeneic stem cell therapy and autologous stem cell therapy. Lucintel forecasts that the allogeneic stem cell therapy market is expected to remain the largest segment due to its increasing application in treating cancer and growing cases of cancer worldwide.

“Within the stem cell therapy market, the musculoskeletal disorders segment is expected to remain the largest application”

Based on application the musculoskeletal disorders segment is expected to witness the highest growth over the forecast period due to the growing number of musculoskeletal disorders, such as orthopedic implant failure, cartilage repair, ligament repair, and carpal tunnel syndrome.

“North America will dominate the stem cell therapy market in near future”

North America is expected to remain the largest region over the forecast period due to well-established healthcare infrastructure with advanced medical facilities, a strong regulatory framework, and development and commercialization of innovative medical technologies.

Download Brochure of this report by clicking on https://www.lucintel.com/stem-cell-therapy-market.aspx

Major players of stem cell therapy market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Smith+Nephew, Medipost, Anterogen, Pharmicell NuVasive, JCR Pharmaceuticals, Orthofix are among the major stem cell therapy providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/stem-cell-therapy-market.aspx or helpdesk@lucintel.com